UnitedHealth Group reported mixed financial results for Q4, with a rise in medical care ratio and CEO's tribute to the late ...
A bill before the Arkansas legislature would prevent pharmacy benefit managers (PBMs) or insurance companies from obtaining ...
UnitedHealthcare's legal drug dealing arm is, according to the government, massively marking up the cost of life-saving ...
Hosted on MSN3h
Report Reveals Billions Made from Generic Drug Price HikesA recent Federal Trade Commission report highlights a concerning trend in the pharmaceutical industry, where pharmacy benefit ...
Andrew Witty, UnitedHealth CEO, said the move will remove an excuse other players use to blame Optum Rx for high drug costs.
Pharmacy benefit managers actually "play a vital role in holding" sometimes-inflated prices down, said UHG CEO Andrew Witty ...
Amid intense criticism, UnitedHealth Group reported a $29 billion increase in 2024 revenues today, up 8% to $400.3 billion.
In an investor call, Andrew Witty promised full transparency and 100% pass-through rebates for prescription drugs by 2028.
Our narrow economic moat rating for UnitedHealth Group reflects our generally narrow-moat view of the US health insurance and PBM industries that includes an unclear outlook for economic profitability ...
FTC: ‘Big 3’ Pharmacy Benefit Managers Engaged in Price Gouging, PBMs, UnitedHealth OptumRx, CVS Caremark Rx, Express Scripts ...
The FTC report found that from 2017 to 2022, three PBMs—UnitedHealth Group's Optum, CVS Health's CVS Caremark and Cigna's Express Scripts—marked up prices at their pharmacies by hundreds or thousands ...
The pharmaceutical industry, grappling with new government limits on drug prices, is focusing its requests for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback